The Repeated Administration of Resveratrol Has Measurable Effects on Circulating T-Cell Subsets in Humans

Figure 1

Pharmacokinetic studies and the parameters of plasma oxidative stress. (a) The plasma levels of resveratrol in samples collected at baseline and after two and four weeks of resveratrol consumption. (b) The total antioxidant activity (TAA) in plasma from healthy individuals measured at baseline and at after two (W2) and four weeks (W4) of study entry. Data is expressed as mean ± standard error. indicates statistical significance. (c) The urinary 8-OHdG levels, adjusted by the creatinine concentration correction method, in four individuals at baseline and after two weeks of resveratrol administration.

(a)

(b)

(c)